[Skip to Navigation]
Sign In
Figure 1.  Cumulative Exposure to Incarceration (Accounting for Competing Risk of Death), Overall and Stratified by Race
Cumulative Exposure to Incarceration (Accounting for Competing Risk of Death), Overall and Stratified by Race

Cumulative incidence function estimates accounted for the competing risk of death to generate curves depicting the unadjusted cumulative incidence of exposure to follow-up incarceration over time. These curves depict the cumulative percentage of participants who had been exposed to at least 1 incarceration during follow-up. Regardless of any prior incarceration at baseline, all participants were considered unexposed to follow-up incarceration at baseline.

Figure 2.  Extended Kaplan-Meier Cumulative Incidence of Death, Stratified by Race and Time-Varying Exposure to Incarceration
Extended Kaplan-Meier Cumulative Incidence of Death, Stratified by Race and Time-Varying Exposure to Incarceration

The extended Kaplan-Meier estimator26 permits calculation of unadjusted cumulative incidence of death curves with a time-varying exposure to incarceration. Technically, extended Kaplan-Meier curves represent hypothetical cohorts whose exposure statuses remain constant throughout follow-up; because this method allows participants to transition between exposure groups during follow-up, we note that each curve cannot be technically interpreted as the percentage of a real cohort with an event over time.27,28

Table 1.  Baseline Characteristics Overall and Stratified by Racea
Baseline Characteristics Overall and Stratified by Racea
Table 2.  Adjusted Hazards From Proportional Subdistribution Model for Time to Incarceration for the Full Cohort, Accounting for Competing Risk of Death (N = 7974)
Adjusted Hazards From Proportional Subdistribution Model for Time to Incarceration for the Full Cohort, Accounting for Competing Risk of Death (N = 7974)
Table 3.  Adjusted Hazards From the Multivariable Cox Regression Models of Death, Overall and Stratified by Race
Adjusted Hazards From the Multivariable Cox Regression Models of Death, Overall and Stratified by Race
1.
Bureau of Justice Statistics. Estimated number of persons supervised by U.S. adult correctional systems, by correctional status, 1980-2018. Key Statistics: Total Correctional Population. May 11, 2021. Accessed November 11, 2021. https://bjs.ojp.gov/data/key-statistics
2.
Maruschak  L, Minton  T. Correctional populations in the United States, 2017-2018. Bureau of Justice Statistics. August 2020. Accessed January 30, 2021. https://bjs.ojp.gov/redirect-legacy/index.cfm?ty=pbdetail&iid=7026
3.
Institute for Crime & Justice Policy Research. Highest to lowest: prison population total. World Prison Brief. Updated December 31, 2020. Accessed January 30, 2021. https://www.prisonstudies.org/highest-to-lowest/prison-population-total
4.
Bailey  ZD, Krieger  N, Agénor  M, Graves  J, Linos  N, Bassett  MT.  Structural racism and health inequities in the USA: evidence and interventions.   Lancet. 2017;389(10077):1453-1463. doi:10.1016/S0140-6736(17)30569-X PubMedGoogle ScholarCrossref
5.
Alexander  M.  The New Jim Crow: Mass Incarceration in the Age of Colorblindness. Rev ed. New Press; 2012.
6.
Sentencing Project. Trends in US corrections. Sentencing Project. Updated May 2021. Accessed November 11, 2021. https://www.sentencingproject.org/wp-content/uploads/2021/07/Trends-in-US-Corrections.pdf
7.
Pettit  B, Western  B.  Mass imprisonment and the life course: race and class inequality in US incarceration.   Am Sociol Rev. 2004;69(2):151-169. doi:10.1177/000312240406900201 Google ScholarCrossref
8.
Woolf  SH, Aron  L.  Failing health of the United States.   BMJ. 2018;360:k496. doi:10.1136/bmj.k496 PubMedGoogle Scholar
9.
Institute of Medicine, National Research Council.  US Health in International Perspective: Shorter Lives, Poorer Health. National Academies Press; 2013.
10.
Wildeman C.  US mass incarceration damages health and shortens lives.   Lancet Public Health. 2019;4(7):e311. doi:10.1016/S2468-2667(19)30114-8 PubMedGoogle Scholar
11.
Wildeman  C.  Incarceration and population health in wealthy democracies.   Criminology. 2016;54(2):360-382. doi:10.1111/1745-9125.12107 Google ScholarCrossref
12.
Nosrati  E, Kang-Brown  J, Ash  M, McKee  M, Marmot  M, King  LP.  Incarceration and mortality in the United States.   SSM Popul Health. 2021;15:100827. doi:10.1016/j.ssmph.2021.100827 PubMedGoogle Scholar
13.
Nowotny  KM, Kuptsevych-Timmer  A.  Health and justice: framing incarceration as a social determinant of health for Black men in the United States.   Sociol Compass. 2018;12(3):e12566. doi:10.1111/soc4.12566 Google Scholar
14.
Wildeman  C, Wang  EA.  Mass incarceration, public health, and widening inequality in the USA.   Lancet. 2017;389(10077):1464-1474. doi:10.1016/S0140-6736(17)30259-3 PubMedGoogle ScholarCrossref
15.
Brinkley-Rubinstein  L.  Incarceration as a catalyst for worsening health.   Health Justice. Published online October 24, 2013. doi:10.1186/2194-7899-1-3 Google Scholar
16.
Binswanger  IA, Blatchford  PJ, Mueller  SR, Stern  MF.  Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.   Ann Intern Med. 2013;159(9):592-600. doi:10.7326/0003-4819-159-9-201311050-00005 PubMedGoogle ScholarCrossref
17.
Merrall  ELC, Kariminia  A, Binswanger  IA,  et al.  Meta-analysis of drug-related deaths soon after release from prison.   Addiction. 2010;105(9):1545-1554. doi:10.1111/j.1360-0443.2010.02990.x PubMedGoogle ScholarCrossref
18.
Wang  EA, Macmadu  A, Rich  JD.  Examining the impact of criminal justice involvement on health through federally funded, national population-based surveys in the United States.   Public Health Rep. 2019;134(1, suppl):22S-33S. doi:10.1177/0033354918824324PubMedGoogle Scholar
19.
Rothstein  DS, Carr  D, Cooksey  E.  Cohort profile: the National Longitudinal Survey of Youth 1979 (NLSY79).   Int J Epidemiol. 2019;48(1):22-22e. doi:10.1093/ije/dyy133 PubMedGoogle ScholarCrossref
20.
US Bureau of Labor Statistics. National Longitudinal Surveys: sample design & screening process (NLSY79). Modified November 11, 2021. Accessed November 11, 2021. https://www.nlsinfo.org/content/cohorts/nlsy79/intro-to-the-sample/sample-design-screening-process
21.
US Bureau of Labor Statistics. National Longitudinal Surveys: race, ethnicity & immigration data (NLSY79). Modified November 11, 2021. Accessed November 11, 2021. https://www.nlsinfo.org/content/cohorts/nlsy79/topical-guide/household/race-ethnicity-immigration-data
22.
Light  A, Nandi  A.  Identifying race and ethnicity in the 1979 National Longitudinal Survey of Youth.   Popul Res Policy Rev. 2007;26(2):125-144.Google ScholarCrossref
23.
Satagopan  JM, Ben-Porat  L, Berwick  M, Robson  M, Kutler  D, Auerbach  AD.  A note on competing risks in survival data analysis.   Br J Cancer. 2004;91(7):1229-1235. doi:10.1038/sj.bjc.6602102 PubMedGoogle ScholarCrossref
24.
Gray  RJ.  A class of K-sample tests for comparing the cumulative incidence of a competing risk.   Ann Stat. 1988;16(3):1141-1154. doi:10.1214/aos/1176350951 Google ScholarCrossref
25.
Fine  JP, Gray  RJ.  A proportional hazards model for the subdistribution of a competing risk.   J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459.1999.10474144 Google ScholarCrossref
26.
Snapinn  SM, Jiang  Q, Iglewicz  B.  Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator.   Am Stat. 2005;59(4):301-307. doi:10.1198/000313005X70371 Google ScholarCrossref
27.
Sjölander  A.  A cautionary note on extended Kaplan-Meier curves for time-varying covariates.   Epidemiology. 2020;31(4):517-522. doi:10.1097/EDE.0000000000001188 PubMedGoogle ScholarCrossref
28.
Beyersmann  J, Gerds  T, Schumacher  M. Letter to the editor: comment on “Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator” by Steven Snapinn, Qi Jiang, and Boris Iglewicz in the November 2005 issue of The American Statistician.  The American Statistician. 2006;60(3):295-297. doi:10.1198/000313006X118700
29.
VanderWeele  TJ, Ding  P.  Sensitivity analysis in observational research: introducing the E-value.   Ann Intern Med. 2017;167(4):268-274. doi:10.7326/M16-2607 PubMedGoogle ScholarCrossref
30.
Massoglia  M, Pare  P-P, Schnittker  J, Gagnon  A.  The relationship between incarceration and premature adult mortality: gender specific evidence.   Soc Sci Res. 2014;46:142-154. doi:10.1016/j.ssresearch.2014.03.002 PubMedGoogle ScholarCrossref
31.
Patterson  EJ.  The dose-response of time served in prison on mortality: New York State, 1989-2003.   Am J Public Health. 2013;103(3):523-528. doi:10.2105/AJPH.2012.301148PubMedGoogle ScholarCrossref
32.
Kajeepeta  S, Rutherford  CG, Keyes  KM, El-Sayed  AM, Prins  SJ.  County jail incarceration rates and county mortality rates in the United States, 1987-2016.   Am J Public Health. 2020;110(S1):S109-S115. doi:10.2105/AJPH.2019.305413 PubMedGoogle ScholarCrossref
33.
Nosrati  E, King  LP.  Punitive social policy and vital inequality.   Int J Health Serv. 2021;51(4):545-558. Published online June 9, 2021. doi:10.1177/00207314211024895PubMedGoogle ScholarCrossref
34.
Nosrati  E, Ash  M, Marmot  M, McKee  M, King  LP.  The association between income and life expectancy revisited: deindustrialization, incarceration and the widening health gap.   Int J Epidemiol. 2018;47(3):720-730. doi:10.1093/ije/dyx243 PubMedGoogle ScholarCrossref
35.
Schnittker  J, John  A.  Enduring stigma: the long-term effects of incarceration on health.   J Health Soc Behav. 2007;48(2):115-130. doi:10.1177/002214650704800202 PubMedGoogle ScholarCrossref
36.
Massoglia  M.  Incarceration, health, and racial disparities in health.   Law Society Rev. 2008;42(2):275-306. doi:10.1111/j.1540-5893.2008.00342.x Google ScholarCrossref
37.
Wacquant  L.  Class, race & hyperincarceration in revanchist America.   Daedalus. 2010;139(3):74-90. doi:10.1162/DAED_a_00024 Google ScholarCrossref
38.
National Research Council.  The Growth of Incarceration in the United States: Exploring Causes and Consequences. National Academies Press; 2014. doi:10.17226/18613
39.
Pfaff  JF.  Locked in: The True Causes of Mass Incarceration—and How to Achieve Real Reform. Basic Books; 2017.
40.
Wooditch  A, Tang  LL, Taxman  FS.  Which criminogenic need changes are most important in promoting desistance from crime and substance use?   Crim Justice Behav. 2014;41(3):276-299. doi:10.1177/0093854813503543 PubMedGoogle ScholarCrossref
41.
Travis  J, Western  B. The era of punitive excess. Brennan Center for Justice at NYU School of Law. April 13, 2021. Accessed July 28, 2021. https://www.brennancenter.org/our-work/analysis-opinion/era-punitive-excess
42.
National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on Law and Justice; Committee on the Best Practices for Implementing Decarceration as a Strategy to Mitigate the Spread of COVID-19 in Correctional Facilities; Schuck J, Backes EP, Western B, Wang EA, eds. Decarcerating Correctional Facilities during COVID-19: Advancing Health, Equity, and Safety. National Academies Press; October 20, 2020. doi:10.17226/25945
43.
Shavit  S, Aminawung  JA, Birnbaum  N,  et al.  Transitions clinic network: challenges and lessons in primary care for people released from prison.   Health Aff (Millwood). 2017;36(6):1006-1015. doi:10.1377/hlthaff.2017.0089 PubMedGoogle ScholarCrossref
44.
Commonwealth Medicine. Commonwealth Medicine collaborates on Massachusetts initiative providing community-based supports for individuals with justice involvement. Commonwealth Medicine website. December 17, 2019. Accessed February 5, 2021. https://commed.umassmed.edu/news/2019/12/17/commonwealth-medicine-collaborates-massachusetts-initiative-providing-community
45.
Karandinos  G, Bourgois  P.  The structural violence of hyperincarceration—a 44-year-old man with back pain.   N Engl J Med. 2019;380(3):205-209. doi:10.1056/NEJMp1811542 PubMedGoogle ScholarCrossref
Original Investigation
Public Health
December 23, 2021

Association of Incarceration With Mortality by Race From a National Longitudinal Cohort Study

Author Affiliations
  • 1Section of General Internal Medicine, Boston Medical Center, Boston, Massachusetts
  • 2The Miriam Hospital, Lifespan, Providence, Rhode Island
  • 3Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts
  • 4Boston University School of Medicine, Boston, Massachusetts
JAMA Netw Open. 2021;4(12):e2133083. doi:10.1001/jamanetworkopen.2021.33083
Key Points

Questions  Is exposure to incarceration associated with a long-term increase in mortality rate, and does this association differ by race?

Findings  In this cohort study of 7974 individuals who were followed up from 1979 to 2018, incarceration was associated with a 65% higher mortality rate among Black participants. Among non-Black participants, incarceration was not associated with mortality.

Meaning  These findings suggest that racial disparities in the association of incarceration with mortality—as well as in rates of exposure to incarceration—may partially explain the lower life expectancy of the non-Hispanic Black population in the US.

Abstract

Importance  The association between incarceration and long-term mortality risk is unknown and may contribute to racial disparities in overall life expectancy.

Objective  To determine whether incarceration in the US is associated with an increase in mortality risk and whether this association is different for Black compared with non-Black populations.

Design, Setting, and Participants  This generational retrospective cohort study used data from the National Longitudinal Survey of Youth 1979, a nationally representative cohort of noninstitutionalized youths aged 15 to 22 years, from January 1 to December 31, 1979, with follow-up through December 31, 2018. A total of 7974 non-Hispanic Black and non-Hispanic non-Black participants were included. Statistical analysis was performed from October 26, 2019, to August 31, 2021.

Exposures  Time-varying exposure of having experienced incarceration during follow-up.

Main Outcomes and Measures  The main outcome was time to death. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs, adjusted for baseline sociodemographic, economic, and behavioral risk factors. Models were evaluated for the full cohort and stratified by race.

Results  Of the 7974 individuals included in our sample, 4023 (50.5%) were male, and 2992 (37.5%) identified as Black (median age, 18 [IQR, 17-20] years). During a median follow-up of 35 years (IQR, 33-37 years), 478 participants were incarcerated and 818 died. Unadjusted exposure to at least 1 incarceration between 22 and 50 years of age was 11.5% (95% CI, 10.4%-12.7%) for Black participants compared with 2.5% (95% CI, 2.1%-2.9%) for non-Black participants. In the multivariable Cox proportional hazards model with the full cohort, time-varying exposure to incarceration was associated with an increased mortality rate (adjusted HR [aHR], 1.35; 95% CI, 0.97-1.88), a result that was not statistically significant. In the models stratified by race, incarceration was significantly associated with increased mortality among Black participants (aHR, 1.65; 95% CI, 1.18-2.31) but not among non-Black participants (aHR, 1.17; 95% CI, 0.68-2.03).

Conclusions and Relevance  In this cohort study with 4 decades of follow-up, incarceration was associated with a higher mortality rate among Black participants but not among non-Black participants. These findings suggest that incarceration, which was prevalent and unevenly distributed, may have contributed to the lower life expectancy of the non-Hispanic Black population in the US.

Introduction

During the era of mass incarceration of the last 4 decades, the incarcerated population in the US has quadrupled in size,1 and the US incarcerates a greater number and proportion of its citizens than any other country in the world.2,3 As a manifestation of structural racism—which Bailey et al define as “the totality of ways in which societies foster racial discrimination, via mutually reinforcing inequitable systems…that in turn reinforce discriminatory beliefs, values, and distribution of resources”4(p1455)—this growth in carceral practices has fallen disproportionately on specific minoritized racial groups, particularly Black men.5,6 Serving time in prison during young adulthood is as common for Black men as college graduation is for White men.7

Life expectancy is worse in the US than in most other high-income countries and has some of the widest disparities across race and class.8,9 The experience of incarceration, which is linked to numerous ill health effects, may contribute to racial health disparities and to the relatively poor health of the population as a whole.10-12 A variety of mechanisms may explain this connection to health, from the stressful disruption of detention and release, to the enduring effects of stigma, decreased earning potential, frayed social bonds, and other challenges that persist long after a person returns home.13-15

However, the true effect of incarceration on life expectancy in the US has been difficult to measure. Studies have documented the increased mortality rates of individuals recently released from prison or jail, particularly due to drug overdose,16,17 but few have examined long-term mortality. Because many of the risk factors for incarceration (eg, poverty, low educational level, experiences of racism) are also social determinants of poor health, it is difficult to disentangle the effect of incarceration from the health effects of these other factors. The longitudinal data that would be necessary to elucidate these associations are limited, because incarceration and involvement in the criminal-legal system are largely ignored in most national health studies.18 In this study, we used one of the longest-running national cohort studies with data on incarceration and a wide variety of other social determinants of health. We sought to determine, first, whether the experience of incarceration during the life course is associated with a higher mortality rate when adjusting for baseline markers of social and economic status, and second, whether the association of incarceration with mortality differs by race.

Methods
Study Design, Data Source, and Cohort Selection

We conducted a retrospective cohort study using data from the National Longitudinal Survey of Youth 1979 (NLSY79). Administered by the US Bureau of Labor Statistics, NLSY79 recruited a nationally representative cohort of noninstitutionalized youth from January 1 to December 31, 1979, who were 15 to 22 years of age, and who have been followed up ever since.19,20 Data were collected via in-person or telephone surveys administered annually from 1979 to 1994 and every 2 years after that. We used data from all 28 survey rounds conducted through December 31, 2018. The Boston University Medical Campus institutional review board determined that this study was not human participant research and did not require informed consent. Reporting in this study followed all applicable Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.

In this study, we included participants if they were in a subsample that was retained in NLSY79 throughout the study period—namely, the cross-sectional civilian sample, the supplemental oversample of non-Hispanic Black participants, and the retained portion of the military sample. We excluded 2 supplemental subsamples that NLSY79 dropped in the first decade owing to funding changes (see eMethods 1 and eFigure 1 in the Supplement for details).

Using the 3 categories defined by NLSY79’s main race and ethnicity variable—Hispanic (of any race), non-Hispanic Black, and non-Hispanic non-Black—we limited our analysis to only the non-Hispanic Black (hereafter, Black) and non-Hispanic non-Black (hereafter, non-Black) groups for clarity of comparison. This race and ethnicity variable relied partly on interviewer-perceived race in addition to participant self-identification and did not allow for reliable differentiation between non-Hispanic White and other non-Hispanic non-Black groups (eg, Asian, Native American) (see eMethods 2 and eTables 1 and 2 in the Supplement for details on our approach to the available race and ethnicity data).21,22

We indexed all longitudinal survey data by participant age in years (rather than calendar year) and started follow-up at 22 years of age, the youngest age with baseline data available for the entire cohort (eFigure 2 in the Supplement). We considered the baseline period to include the surveys completed by a participant at or before 22 years of age. We excluded participants who died or were lost to follow-up before 22 years of age. Participants remained in our study cohort until death or censoring (loss to follow-up or the end of the study period).

Key Variables

The outcome was death, identified as the reason for noninterview in survey rounds after a participant’s death. We considered participants to be alive up until the year they were recorded as deceased in a survey response.

For the exposure, we used 3 sets of survey variables to identify incarcerations: in 1980, survey participants were asked if they had ever been incarcerated and, if so, the date of their last release; in subsequent surveys, we identified incarceration if a participant’s residence was recorded as jail/prison or if they were not surveyed and the reason recorded was incarceration. We note that incarceration as a possible reason for noninterview was first introduced with the 2004 survey. Our primary exposure was time-varying incarceration after 22 years of age, the start of follow-up for these analyses. This design established a uniform time zero at which to identify baseline characteristics that are potential confounders and from which to follow up for the exposure and outcome of interest. We operationalized incarceration as a yearly time-dependent dichotomous exposure variable: participants were considered unexposed to follow-up incarceration until they experienced an incarceration in this period and were considered exposed thereafter. We characterized any incarceration before 22 years of age in a separate baseline variable, prior incarceration.

We identified important baseline characteristics that may be potential confounders. We included participants’ sex. We defined baseline disability as reporting a health condition that prevented one from working or limited the amount or type of work one could do. We identified whether participants received a high school diploma or equivalent by 22 years of age. We dichotomized parental high school completion as both parents completed high school vs at least 1 parent did not complete high school or had missing data. As a marker of poverty, we identified whether participants reported income from public assistance or welfare programs during the baseline period. We scaled total annual family income as a percentage of the year-specific federal poverty level and used the mean of all available values during the baseline period. From the 1980 survey, we assessed whether participants reported any illicit drug use and any engagement in illegal activity in the past 12 months.

Statistical Analysis

Statistical analysis was performed from October 26, 2019, to August 31, 2021. We analyzed both time to incarceration and time to death. We used cumulative incidence function estimates, which accounted for the competing risk of death23 to generate unadjusted cumulative exposure to incarceration curves and tested for between-group difference by race using the Gray nonparametric test.24 We modeled the cumulative incidence function of incarceration exposure using a proportional subdistribution hazards regression model accounting for the competing risk of death25 and adjusted for the following baseline characteristics: prior incarceration, race, sex, disability, income, receipt of public assistance, participant high school completion, parental high school completion, drug use, and illegal activity. For the time-to-death analysis, we used an extended Kaplan-Meier estimator26 allowing for time-varying incarceration exposure to generate unadjusted cumulative incidence of death curves. Extended Kaplan-Meier curves represent hypothetical cohorts whose exposure statuses remain constant throughout follow-up (so they are not to be interpreted as the percentage of a real cohort with an event over time).27,28 We modeled time to death using a standard Cox proportional hazards regression model with follow-up incarceration as a time-dependent exposure variable and the other covariates included in the time-to-incarceration model. To evaluate whether race modifies the effect of incarceration on mortality, we analyzed race-stratified versions of the model. Due to the NLSY79’s cluster-sampling design, we included sample weights and adjusted our time-to-death regression models to account for potential similarities among participants within each geographic cluster (ie, primary sampling unit). For any significant association between incarceration and mortality, we calculated E-values to assess the minimum strength of association (expressed on a hazard ratio [HR] scale) that an unmeasured confounder would need to have with both incarceration and mortality, controlling for all measured covariates, to explain away the observed association.29

We used multiple imputation with 10 imputations to account for missing data among baseline covariates. We further examined the impact of potentially informative missingness by performing a complete case analysis (ie, excluding participants with any missing covariate data from the sample). To assess the impact of excluding 2 of the NLSY79’s original subsamples (eMethods 1 in the Supplement), we performed a sensitivity analysis by including all non-Hispanic subsamples, censoring participants if or when their subsample was dropped early by the NLSY79. To examine the impact of specifying 2 separate incarceration variables, we conducted a sensitivity analysis by creating a unified time-dependent incarceration variable that considered participants with baseline prior incarceration to be exposed at the start of follow-up. We used SAS, version 9.4 (SAS Institute Inc) for all analyses. Two-sided P < .05 indicated statistical significance.

Results
Baseline Characteristics

Of 12 686 participants in the NLSY79 cohort, we identified 7974 meeting inclusion criteria (eFigure 1 in the Supplement). Data for 1 or more baseline covariates were missing for 789 participants (9.9%) (Table 1). In our study sample, 4023 participants (50.5%) were male, 3951 were female (49.5%), 2992 (37.5%) identified as Black, and 4982 (62.5%) identified as non-Black (median age at study entry, 18 [IQR, 17-20] years). Black and non-Black participants were similar in age distribution (eg, 21-22 years, 638 [21.3%] vs 1126 [22.6%]), sex (male, 1520 [50.8%] vs 2503 [50.2%]), and baseline disability (207 [6.9%] vs 260 [5.2%]). At baseline, non-Black participants were less likely to have a low income (median percentage of federal poverty level, 291% [IQR, 197%-414%] vs 142% [IQR, 85%-223%]) or receipt of public assistance (617 [12.4%] vs 908 [30.3%]), less likely to have not completed high school (697 [14.0%] vs 672 [22.5%]), and less likely to have at least 1 parent who did not complete high school (2206 [44.3%] vs 2245 [75.0%]). Black participants had a lower prevalence of past-year illicit drug use (1146 [41.0%] vs 2404 [51.3%]). At baseline, 219 participants (2.7%) had experienced at least 1 prior incarceration, which was less common among non-Black compared with Black participants (100 [2.0%] vs 119 [4.0%], respectively).

Exposure to Incarceration

During a median follow-up time of 35 years (IQR, 33-37 years), 478 of 7974 participants (6.0%) were incarcerated at least once. Unadjusted cumulative incidence of incarceration was significantly higher among Black compared with non-Black participants throughout follow-up (χ21 = 280.53; P < .001), and by 50 years of age, race-specific cumulative incidences of incarceration were 11.5% (95% CI, 10.4%-12.7%) and 2.5% (95% CI, 2.1%-2.9%), respectively (Figure 1). In the proportional subdistribution hazards model that accounted for competing risk of death, we found that the adjusted rate of incarceration exposure was higher among Black participants (adjusted HR [aHR], 3.47; 95% CI, 2.74-4.39) and among those who had prior incarceration at baseline (aHR, 5.88; 95% CI, 4.53-7.63), past-year illicit drug use (aHR, 1.55; 95% CI, 1.24-1.93), and past-year illegal activity (aHR 1.47; 95% CI, 1.10-1.96) (Table 2).

Mortality

We identified 818 deaths (10.3% of sample) during follow-up. Based on data from the full cohort (eFigure 3 in the Supplement) and from each racial group (Figure 2), cumulative incidence curves using an extended Kaplan-Meier estimator demonstrated a consistently higher cumulative incidence of death among a hypothetical cohort of those with past incarceration exposure from the start compared with one whose members were never exposed. In the Cox proportional hazard regression models, time-varying incarceration was associated with an increased rate of death that was not statistically significant (aHR, 1.35; 95% CI, 0.97-1.88) (Table 3). Prior incarceration was not associated with mortality (aHR, 1.02; 95% CI, 0.65-1.60). Compared with non-Black participants, Black participants had significantly higher mortality rates (aHR, 1.28; 95% CI, 1.08-1.52; E-values, 1.88 for main estimate and 1.37 for lower bound of the 95% CI). In the analysis stratified by race, incarceration was the factor with the strongest association with mortality among Black participants (aHR, 1.65; 95% CI, 1.18-2.31; E-values, 2.68 for main estimate and 1.63 for the lower bound of the 95% CI), but this association was not significant among non-Black participants (aHR, 1.17; 95% CI, 0.68-2.03) (Table 3).

Sensitivity analyses using complete case analysis (eTable 3 in the Supplement) and all non-Hispanic NLSY79 subsamples (eTable 4 in the Supplement) both had very similar findings to our main analysis. Sensitivity analysis with a single, unified time-varying incarceration exposure variable yielded incarceration-mortality associations that were stronger than those in our main analysis, including a statistically significant result in the full cohort model (aHR, 1.45; 95% CI, 1.12-1.88) (eTable 5 in the Supplement).

Discussion

In a nationally representative, longitudinal cohort of 7974 non-Hispanic individuals who were followed up for nearly 4 decades, we found that experiencing an incarceration in adulthood was associated with lower life expectancy for Black but not for non-Black participants. Our study confirmed known racial disparities in rates of incarceration and life expectancy. Collectively, these data suggest that incarceration may be a key mediator of differential life expectancy between Black and non-Black populations in the US—a mediator that is a modifiable target for policy interventions.

Our study adds to the limited existing evidence regarding the association of incarceration with life expectancy and with racial health disparities. A prior study by Massoglia and colleagues30 that also used the NLSY79 data followed up participants to 47 years of age and found an association between incarceration and premature mortality only among women. Our study extends this previous one by including an additional decade of follow-up time (and nearly twice as many deaths) and by using survival analysis methods. In a retrospective cohort of all individuals released on parole from New York state prisons between 1989 and 1993, 1 study31 demonstrated that each additional year of prison time was associated with a nearly 2-year decline in postrelease life expectancy. However, most (>90%) of the sample was followed up for less than 4 years after release. Beyond the scarcity of relevant cohort studies, multiple recent studies using longitudinal ecological designs found associations between local increases in incarceration rates and increases in mortality among the whole population at the county level12,32,33 and among the bottom income quartile at the state level.34

Because very few prior studies have examined the contribution of incarceration to any kind of racial health disparities,14 our study provides the most direct evidence to date, to our knowledge, on the association between mass incarceration and racial disparities in life expectancy. Other studies using the NLSY79 data found that prior incarceration contributed marginally to racial disparities in disability35 and contributed substantially to disparities in general health functioning at 40 years of age.36 Furthermore, the results of our overall and race-stratified analysis indicate that the racial disparity of incarceration’s impact on health is driven by 2 mechanisms: (1) disparate rates of exposure to incarceration and (2) a disparate magnitude of effect on individuals who have been incarcerated. In addition, the fact that a higher risk of mortality remained for Black participants, even after we adjusted for socioeconomic and behavioral risk factors, suggests that our models do not adequately account for all the mechanisms by which structural racism creates health disparities. These could include tobacco and alcohol use, family wealth, broader community-level factors such as residential segregation, and any effects that are a function of cumulative exposure over time (because we only measured covariates at baseline).

With growing evidence of the negative association of incarceration with health disparities, ambitious, wide-ranging policy changes are needed to address the complex, mutually reinforcing factors that (re)produce both structural racism generally and mass incarceration specifically.37-39 Although reforms to criminal-legal systems themselves could help to mitigate the disparate consequences, substantial progress may be elusive without simultaneous improvements in interrelated areas such as economic opportunity, residential segregation, and mental health care, among others.4 To the extent that the social determinants of crime are also determinants of poor health,40 public health proponents can highlight how decarceration and greater investment in communities need not come at the expense of public safety.41,42 For the millions of individuals already affected by carceral systems, multidisciplinary supports are needed to better meet their compounded health and social needs.43,44 Health care clinicians should be able to engage with patients about personal histories of incarceration and understand the effects they can have on their health.45

Limitations

Our study has several limitations. Because the NLSY79 cohort consists only of individuals born from 1957 to 1964, our results might not be generalizable to other birth cohorts. The NLSY79 race and ethnicity variable conflates 2 different types of measures (interviewer-perceived and self-reported), which resulted in a small amount of misclassification, although likely 5% or less (eMethods 2 and eTables 1 and 2 in the Supplement). Data on social, economic, and behavioral covariates were all based on self-report, which may introduce certain biases. Missingness of baseline covariate data may have been informative. However, fewer than 10% of participants had missing data, and results from the complete case sensitivity analysis were similar to those of the primary multiple imputation approach. Because our data source only detects incarcerations that occur at the time of an annual or biannual survey round, many incarcerations, especially shorter ones, are likely to be missed, leading to misclassification of exposure status; there is no way to know whether this misclassification differs in a systematic way that would bias our results.

Because many social and economic factors may function as mediators as well as confounders, we measured covariates only at baseline to avoid attenuating an association between incarceration and mortality by controlling for potential mediators. Limiting our main exposure variable to incarcerations after 22 years of age potentially limits the generalizability of our main analysis (and possibly underestimates incarceration’s full effect, as suggested by our sensitivity analysis with a unified incarceration variable [eTable 5 in the Supplement]), but we made this decision to avoid the potential bias of measuring the exposure before baseline covariates. Moreover, by including earlier incarcerations as a separate baseline variable, we were still able to include all the incarcerations in our data. Our analyses do not account for some potential baseline confounders (such as tobacco use, alcohol use, or family wealth, which were not surveyed in the earliest years of the NLSY79) nor for the possibility of time-dependent confounders.

Conclusions

The findings of this study suggest that in the US, incarceration may contribute to the lower life expectancy of Black US residents. After 4 decades of mass incarceration, contact with the criminal-legal system is prevalent and unevenly distributed, and data are increasingly clear that it has a negative association with individual and population health. Efforts toward health equity and racial justice must consider the role of the criminal-legal system as a social determinant of health and a manifestation of structural racism.

Back to top
Article Information

Accepted for Publication: September 2, 2021.

Published: December 23, 2021. doi:10.1001/jamanetworkopen.2021.33083

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Bovell-Ammon BJ et al. JAMA Network Open.

Corresponding Author: Benjamin J. Bovell-Ammon, MD, MPH, Section of General Internal Medicine, Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118 (benjamin.bovell-ammon@bmc.org).

Author Contributions: Dr Bovell-Ammon had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Bovell-Ammon, Paasche-Orlow, LaRochelle.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Bovell-Ammon.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Bovell-Ammon, Xuan.

Administrative, technical, or material support: Bovell-Ammon, Paasche-Orlow, LaRochelle.

Supervision: Paasche-Orlow, LaRochelle.

Conflict of Interest Disclosures: Dr LaRochelle reported receiving consulting funds for research paid to his institution by OptumLabs. No other disclosures were reported.

Funding/Support: This study was supported by training grants 5T32DA013911 (HIV and Other Infectious Consequences of Substance Abuse) and 5R25DA037190 (Lifespan/Brown Criminal Justice Research Training Program on Substance Use and HIV) from the National Institute on Drug Abuse to The Miriam Hospital, Lifespan (Dr Bovell-Ammon), and by training grant T32-HP10028 from US Health Resources and Services Administration for a faculty mentor (Dr Xuan).

Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Disclaimer: The views expressed herein do not necessarily reflect the views of the Bureau of Labor Statistics.

Additional Information: This research was conducted with restricted access to Bureau of Labor Statistics data.

References
1.
Bureau of Justice Statistics. Estimated number of persons supervised by U.S. adult correctional systems, by correctional status, 1980-2018. Key Statistics: Total Correctional Population. May 11, 2021. Accessed November 11, 2021. https://bjs.ojp.gov/data/key-statistics
2.
Maruschak  L, Minton  T. Correctional populations in the United States, 2017-2018. Bureau of Justice Statistics. August 2020. Accessed January 30, 2021. https://bjs.ojp.gov/redirect-legacy/index.cfm?ty=pbdetail&iid=7026
3.
Institute for Crime & Justice Policy Research. Highest to lowest: prison population total. World Prison Brief. Updated December 31, 2020. Accessed January 30, 2021. https://www.prisonstudies.org/highest-to-lowest/prison-population-total
4.
Bailey  ZD, Krieger  N, Agénor  M, Graves  J, Linos  N, Bassett  MT.  Structural racism and health inequities in the USA: evidence and interventions.   Lancet. 2017;389(10077):1453-1463. doi:10.1016/S0140-6736(17)30569-X PubMedGoogle ScholarCrossref
5.
Alexander  M.  The New Jim Crow: Mass Incarceration in the Age of Colorblindness. Rev ed. New Press; 2012.
6.
Sentencing Project. Trends in US corrections. Sentencing Project. Updated May 2021. Accessed November 11, 2021. https://www.sentencingproject.org/wp-content/uploads/2021/07/Trends-in-US-Corrections.pdf
7.
Pettit  B, Western  B.  Mass imprisonment and the life course: race and class inequality in US incarceration.   Am Sociol Rev. 2004;69(2):151-169. doi:10.1177/000312240406900201 Google ScholarCrossref
8.
Woolf  SH, Aron  L.  Failing health of the United States.   BMJ. 2018;360:k496. doi:10.1136/bmj.k496 PubMedGoogle Scholar
9.
Institute of Medicine, National Research Council.  US Health in International Perspective: Shorter Lives, Poorer Health. National Academies Press; 2013.
10.
Wildeman C.  US mass incarceration damages health and shortens lives.   Lancet Public Health. 2019;4(7):e311. doi:10.1016/S2468-2667(19)30114-8 PubMedGoogle Scholar
11.
Wildeman  C.  Incarceration and population health in wealthy democracies.   Criminology. 2016;54(2):360-382. doi:10.1111/1745-9125.12107 Google ScholarCrossref
12.
Nosrati  E, Kang-Brown  J, Ash  M, McKee  M, Marmot  M, King  LP.  Incarceration and mortality in the United States.   SSM Popul Health. 2021;15:100827. doi:10.1016/j.ssmph.2021.100827 PubMedGoogle Scholar
13.
Nowotny  KM, Kuptsevych-Timmer  A.  Health and justice: framing incarceration as a social determinant of health for Black men in the United States.   Sociol Compass. 2018;12(3):e12566. doi:10.1111/soc4.12566 Google Scholar
14.
Wildeman  C, Wang  EA.  Mass incarceration, public health, and widening inequality in the USA.   Lancet. 2017;389(10077):1464-1474. doi:10.1016/S0140-6736(17)30259-3 PubMedGoogle ScholarCrossref
15.
Brinkley-Rubinstein  L.  Incarceration as a catalyst for worsening health.   Health Justice. Published online October 24, 2013. doi:10.1186/2194-7899-1-3 Google Scholar
16.
Binswanger  IA, Blatchford  PJ, Mueller  SR, Stern  MF.  Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009.   Ann Intern Med. 2013;159(9):592-600. doi:10.7326/0003-4819-159-9-201311050-00005 PubMedGoogle ScholarCrossref
17.
Merrall  ELC, Kariminia  A, Binswanger  IA,  et al.  Meta-analysis of drug-related deaths soon after release from prison.   Addiction. 2010;105(9):1545-1554. doi:10.1111/j.1360-0443.2010.02990.x PubMedGoogle ScholarCrossref
18.
Wang  EA, Macmadu  A, Rich  JD.  Examining the impact of criminal justice involvement on health through federally funded, national population-based surveys in the United States.   Public Health Rep. 2019;134(1, suppl):22S-33S. doi:10.1177/0033354918824324PubMedGoogle Scholar
19.
Rothstein  DS, Carr  D, Cooksey  E.  Cohort profile: the National Longitudinal Survey of Youth 1979 (NLSY79).   Int J Epidemiol. 2019;48(1):22-22e. doi:10.1093/ije/dyy133 PubMedGoogle ScholarCrossref
20.
US Bureau of Labor Statistics. National Longitudinal Surveys: sample design & screening process (NLSY79). Modified November 11, 2021. Accessed November 11, 2021. https://www.nlsinfo.org/content/cohorts/nlsy79/intro-to-the-sample/sample-design-screening-process
21.
US Bureau of Labor Statistics. National Longitudinal Surveys: race, ethnicity & immigration data (NLSY79). Modified November 11, 2021. Accessed November 11, 2021. https://www.nlsinfo.org/content/cohorts/nlsy79/topical-guide/household/race-ethnicity-immigration-data
22.
Light  A, Nandi  A.  Identifying race and ethnicity in the 1979 National Longitudinal Survey of Youth.   Popul Res Policy Rev. 2007;26(2):125-144.Google ScholarCrossref
23.
Satagopan  JM, Ben-Porat  L, Berwick  M, Robson  M, Kutler  D, Auerbach  AD.  A note on competing risks in survival data analysis.   Br J Cancer. 2004;91(7):1229-1235. doi:10.1038/sj.bjc.6602102 PubMedGoogle ScholarCrossref
24.
Gray  RJ.  A class of K-sample tests for comparing the cumulative incidence of a competing risk.   Ann Stat. 1988;16(3):1141-1154. doi:10.1214/aos/1176350951 Google ScholarCrossref
25.
Fine  JP, Gray  RJ.  A proportional hazards model for the subdistribution of a competing risk.   J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459.1999.10474144 Google ScholarCrossref
26.
Snapinn  SM, Jiang  Q, Iglewicz  B.  Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator.   Am Stat. 2005;59(4):301-307. doi:10.1198/000313005X70371 Google ScholarCrossref
27.
Sjölander  A.  A cautionary note on extended Kaplan-Meier curves for time-varying covariates.   Epidemiology. 2020;31(4):517-522. doi:10.1097/EDE.0000000000001188 PubMedGoogle ScholarCrossref
28.
Beyersmann  J, Gerds  T, Schumacher  M. Letter to the editor: comment on “Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator” by Steven Snapinn, Qi Jiang, and Boris Iglewicz in the November 2005 issue of The American Statistician.  The American Statistician. 2006;60(3):295-297. doi:10.1198/000313006X118700
29.
VanderWeele  TJ, Ding  P.  Sensitivity analysis in observational research: introducing the E-value.   Ann Intern Med. 2017;167(4):268-274. doi:10.7326/M16-2607 PubMedGoogle ScholarCrossref
30.
Massoglia  M, Pare  P-P, Schnittker  J, Gagnon  A.  The relationship between incarceration and premature adult mortality: gender specific evidence.   Soc Sci Res. 2014;46:142-154. doi:10.1016/j.ssresearch.2014.03.002 PubMedGoogle ScholarCrossref
31.
Patterson  EJ.  The dose-response of time served in prison on mortality: New York State, 1989-2003.   Am J Public Health. 2013;103(3):523-528. doi:10.2105/AJPH.2012.301148PubMedGoogle ScholarCrossref
32.
Kajeepeta  S, Rutherford  CG, Keyes  KM, El-Sayed  AM, Prins  SJ.  County jail incarceration rates and county mortality rates in the United States, 1987-2016.   Am J Public Health. 2020;110(S1):S109-S115. doi:10.2105/AJPH.2019.305413 PubMedGoogle ScholarCrossref
33.
Nosrati  E, King  LP.  Punitive social policy and vital inequality.   Int J Health Serv. 2021;51(4):545-558. Published online June 9, 2021. doi:10.1177/00207314211024895PubMedGoogle ScholarCrossref
34.
Nosrati  E, Ash  M, Marmot  M, McKee  M, King  LP.  The association between income and life expectancy revisited: deindustrialization, incarceration and the widening health gap.   Int J Epidemiol. 2018;47(3):720-730. doi:10.1093/ije/dyx243 PubMedGoogle ScholarCrossref
35.
Schnittker  J, John  A.  Enduring stigma: the long-term effects of incarceration on health.   J Health Soc Behav. 2007;48(2):115-130. doi:10.1177/002214650704800202 PubMedGoogle ScholarCrossref
36.
Massoglia  M.  Incarceration, health, and racial disparities in health.   Law Society Rev. 2008;42(2):275-306. doi:10.1111/j.1540-5893.2008.00342.x Google ScholarCrossref
37.
Wacquant  L.  Class, race & hyperincarceration in revanchist America.   Daedalus. 2010;139(3):74-90. doi:10.1162/DAED_a_00024 Google ScholarCrossref
38.
National Research Council.  The Growth of Incarceration in the United States: Exploring Causes and Consequences. National Academies Press; 2014. doi:10.17226/18613
39.
Pfaff  JF.  Locked in: The True Causes of Mass Incarceration—and How to Achieve Real Reform. Basic Books; 2017.
40.
Wooditch  A, Tang  LL, Taxman  FS.  Which criminogenic need changes are most important in promoting desistance from crime and substance use?   Crim Justice Behav. 2014;41(3):276-299. doi:10.1177/0093854813503543 PubMedGoogle ScholarCrossref
41.
Travis  J, Western  B. The era of punitive excess. Brennan Center for Justice at NYU School of Law. April 13, 2021. Accessed July 28, 2021. https://www.brennancenter.org/our-work/analysis-opinion/era-punitive-excess
42.
National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Committee on Law and Justice; Committee on the Best Practices for Implementing Decarceration as a Strategy to Mitigate the Spread of COVID-19 in Correctional Facilities; Schuck J, Backes EP, Western B, Wang EA, eds. Decarcerating Correctional Facilities during COVID-19: Advancing Health, Equity, and Safety. National Academies Press; October 20, 2020. doi:10.17226/25945
43.
Shavit  S, Aminawung  JA, Birnbaum  N,  et al.  Transitions clinic network: challenges and lessons in primary care for people released from prison.   Health Aff (Millwood). 2017;36(6):1006-1015. doi:10.1377/hlthaff.2017.0089 PubMedGoogle ScholarCrossref
44.
Commonwealth Medicine. Commonwealth Medicine collaborates on Massachusetts initiative providing community-based supports for individuals with justice involvement. Commonwealth Medicine website. December 17, 2019. Accessed February 5, 2021. https://commed.umassmed.edu/news/2019/12/17/commonwealth-medicine-collaborates-massachusetts-initiative-providing-community
45.
Karandinos  G, Bourgois  P.  The structural violence of hyperincarceration—a 44-year-old man with back pain.   N Engl J Med. 2019;380(3):205-209. doi:10.1056/NEJMp1811542 PubMedGoogle ScholarCrossref
×